William B. Wong

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Sheila Lumley, Jia Wei, Denise O’Donnell et al. · Clinical Infectious Diseases · 2021 · 306 citations · Full text

Assessment of costs associated with adverse events in patients with cancer

William B. Wong, Yeun Mi Yim, Ashley Kim et al. · PLoS ONE · 2018 · 158 citations · Full text

Cancer Management, Epidemiology Of Cancer, Cancer Registration +22

The Catecholamine Release-Inhibitory “Catestatin” Fragment of Chromogranin A: Naturally Occurring Human Variants with Different Potencies for Multiple Chromaffin Cell Nicotinic Cholinergic Responses

Sushil K. Mahata, Manjula Mahata, Gen Wen et al. · Molecular Pharmacology · 2004 · 87 citations

The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007)

William B. Wong, Scott D. Ramsey, William E. Barlow et al. · Contemporary Clinical Trials · 2012 · 46 citations · Full text

Swog S1007, Meta-analysis, Health Policy +8

ALK Testing Trends and Patterns Among Community Practices in the United States

Peter B. Illei, William B. Wong, Ning Wu et al. · JCO Precision Oncology · 2018 · 44 citations · Full text